Abstract
Diabetes mellitus (DM) and its complications, including myocardial infarction (MI), coronary artery disease (CAD), nephropathy, and peripheral arterial disease (PAD) resulted in 6.7 million deaths in 2021. Myocardial infarction is one of the leading causes of mortality in both insulin-dependent DM (IDDM) and non-insulin-dependent DM (NIDDM) individuals. In addition, diabetic patients with acute MI (AMI) experience poor outcomes after percutaneous coronary intervention (PCI), with a higher risk of restenosis eventually necessitating coronary artery bypass grafting (CABG). The optimal timing to perform CABG on diabetic patients with AMI remains a topic of debate, particularly in achieving better short-term and long-term outcomes between NIDDM and IDDM cohorts.